NCT03424005 2026-03-16
Morpheus-panBC
Hoffmann-La Roche
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT06596018 2025-12-30
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Recruiting
NCT07161791 2025-09-09
Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer
Harbin Medical University
Phase 1/2 Not yet recruiting
NCT04004910 2022-03-24
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Immunicom Inc
Phase 1/2 Unknown
NCT03175341 2018-06-27
Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer
Academic Emergency County Hospital Sibiu
Phase 1/2 Unknown
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed